Company: CWAN
Filing Date: 2025-02-11
Form Type: S-4
Source: 0001193125-25-023759
Chunk: 36

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-02-11
Form: S-4
Chunk 36
---
 of the stock consideration will fluctuate as the market price of Clearwater Common Stock fluctuates because the stock consideration is payable in a fixed number of shares of Clearwater Common Stock. As a result, the value of the stock consideration that holders of Eligible Shares will receive upon completion of the Merger could be greater than, less than or the same as the value of the stock consideration on the date of this Proxy Statement/Prospectus, at the time of the Special Meeting or on the date on which holders of Eligible Shares make their election, but in any event, will be subject to a 10% collar when compared to the value of a share of Clearwater Common Stock, as agreed to among the parties in the Merger Agreement. Accordingly, Enfusion and Clearwater encourage you to obtain current stock price quotations for Clearwater Common Stock before deciding how to vote with respect to the Merger Agreement proposal. Clearwater Common Stock and Enfusion Common Stock trade on the New York Stock Exchange, under the symbols “ENFN” and “CWAN,” respectively. The Special Meeting(see page 44) Purposes of the Special Meeting At the Special Meeting, Enfusion Stockholders will be asked to vote upon the following proposals:

| • |     | The Merger Agreement Proposal; and |

| • |     | The Adjournment Proposal. |

Record Date The record date for the determination of stockholders entitled to notice of and to vote at the Special Meeting is , 2025. Only Enfusion Stockholders who held shares of record as of the close of business on the record date are entitled to receive notice of and to vote at the Special Meeting and any adjournment or postponement of the Special Meeting, as long as such shares remain outstanding on the date of the Special Meeting. Enfusion’s official stock ownership records will conclusively determine whether a stockholder is a “holder of record” as of the record date.

18

Required Vote

| • |     | Proposal 1—The Merger Agreement Proposal. The affirmative vote, virtually or by proxy, of holders of                                                                                                             
 at least a majority of the outstanding shares of Enfusion Common Stock and Enfusion Class B Common Stock entitled to vote on the Merger Agreement Proposal is required to approve the Merger Agreement Proposal. |

| • |     | Proposal 2—The Adjournment Proposal. The affirmative vote, virtually or by proxy, of a majority of                                                                                          
 the votes properly cast by holders of shares of Enfusion Common Stock and En